Sorry, you need to enable JavaScript to visit this website.
The recent Alfamino recall does not impact the United States. Alfamino and all other Nestlé products in the U.S. are safe to consume. Learn more

Commercial Blenderized Tube Feeding Formulas: Recent Evidence Supports Improved Clinical and Health Economic Outcomes

Taught by
Katherine H. Bennett
Katherine H. Bennett, MPH, RD, CLEC
Clinical Dietitian IV Children’s Hospital of Orange County - Orange, CA
Amarsinh Desai
Amarsinh Desai, PhD, MS, BPharm, DPharm
Lead, Health Economics and Market Access - Nestlé Health Science
Aimee Henrikson
Aimee Henrikson, MPH, RDN, LDN
Manager, Medical Affairs Nestlé Health Science
Duration
60
min

About this Webinar

Learning Objectives:
1. Explain recently published real world evidence on the clinical and health economic outcomes of utilizing commercially blenderized formulas for tube-fed children and adults.
2. Describe at least two examples of how this recent data will change clinical practice.
3. Apply learnings through a case-based approach to identify how and when to utilize commercially blenderized formulas with tube fed patients.